XML 23 R7.htm IDEA: XBRL DOCUMENT v3.24.0.1
Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Cash flows from operating activities:      
Consolidated net income $ 37,781 $ 11,157 $ 51,262
Adjustments to reconcile net income to net cash provided by operating activities:      
Gain on extinguishment of debt (1,664) (885) (2,154)
Loss (gain) on sale of property, plant, and equipment 90 (9) (54)
Loss on goodwill impairment 0 25,585 0
Loss on intangible asset impairment 0 1,981 0
Gain on insurance recovery of inventory loss (15,181) 0 0
Loss on investments 12,177 13,570 7,100
Depreciation and other amortization expense 3,262 3,388 3,105
Amortization of other intangible assets 3,096 1,911 1,907
Amortization of deferred financing costs 2,445 2,576 2,541
Deferred income tax expense (benefit) 7,024 (6,506) (1,485)
Stock compensation expense 6,561 5,273 7,557
Noncash lease income (82) (29) (167)
Gain on MSA escrow deposits 0 (54) (255)
Changes in operating assets and liabilities:      
Accounts receivable (1,609) (2,103) 3,317
Inventories 20,977 (32,653) (9)
Other current assets (3,533) 4,581 (134)
Other assets (4,835) 420 996
Accounts payable (14) 1,240 (2,367)
Accrued liabilities and other 386 830 (2,943)
Net cash provided by operating activities 66,881 30,273 68,217
Cash flows from investing activities:      
Capital expenditures (5,707) (7,685) (6,156)
Acquisitions, net of cash acquired 0 0 (16,416)
Payments for investments (202) (1,000) (16,657)
Restricted cash, MSA escrow deposits 0 (10,170) (19,664)
Proceeds on sale of property, plant and equipment 3 62 54
Net cash used in investing activities (5,906) (18,793) (58,839)
Cash flows from financing activities:      
Proceeds from Senior Notes 0 0 250,000
Payments of 2018 first lien term loan 0 0 (130,000)
Settlement of interest rate swaps 0 0 (3,573)
Convertible Senior Notes repurchased (41,794) (9,000) 0
Proceeds from call options 114 51 0
Payment of promissory note 0 0 (9,625)
Payment of dividends (4,497) (4,250) (4,096)
Payments of financing costs (2,437) 0 (6,921)
Exercise of options 450 504 2,071
Redemption of options (346) (155) (2,111)
Redemption of restricted stock units (995) (1,229) 0
Common stock repurchased 0 (29,224) (38,678)
Net cash (used in) provided by financing activities (49,505) (43,303) 57,067
Net increase (decrease) in cash 11,470 (31,823) 66,445
Effect of foreign currency translation on cash 13 (320) 191
Cash, beginning of period:      
Unrestricted 106,403 128,320 41,765
Restricted 4,929 15,155 35,074
Total cash at beginning of period 111,332 143,475 76,839
Cash, end of period:      
Unrestricted 117,886 106,403 128,320
Restricted 4,929 4,929 15,155
Total cash at end of period 122,815 111,332 143,475
Supplemental disclosures of cash flow information:      
Cash paid during the period for interest 18,047 18,717 12,539
Cash paid during the period for income taxes, net 12,447 13,369 16,063
Supplemental schedule of noncash investing activities:      
Accrued capital expenditures 8 11 0
Accrued consideration for acquisition of investments 248 0 0
Supplemental schedule of noncash financing activities:      
Dividends declared not paid $ 1,489 $ 1,354 $ 1,261